Travere Therapeutics, Inc. - COMMON STOCK (TVTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
TVTX on Nasdaq
Shares outstanding
90,318,827
Price per share
$38.21
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
100,723,656
Total reported value
$2,407,289,690
% of total 13F portfolios
0%
Share change
-180,662
Value change
+$19,761,117
Number of holders
233
Price from insider filings
$38.21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12% -6.9% $253,331,874 -$17,690,876 10,599,660 -6.5% JANUS HENDERSON GROUP PLC 30 Sep 2025
FMR LLC 12% $403,768,185 10,567,303 FMR LLC 31 Dec 2025
ARMISTICE CAPITAL, LLC 7.5% -25% $160,703,600 -$51,337,200 6,724,000 -24% Armistice Capital, LLC 30 Sep 2025
BlackRock, Inc. 7.5% -21% $90,240,478 -$17,926,281 6,689,435 -17% BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 6.7% +18% $128,337,599 +$20,987,431 5,994,283 +20% The Vanguard Group 30 Jun 2025
PERCEPTIVE ADVISORS LLC 5.5% $117,005,198 4,895,615 Perceptive Advisors LLC 06 Oct 2025
MACQUARIE GROUP LTD 5.4% +10% $64,715,766 +$7,254,342 4,797,314 +13% Macquarie Group Limited 31 Mar 2025
Rock Springs Capital Management LP 3.3% -40% $39,406,934 -$27,687,591 2,921,196 -41% Rock Springs Capital Management LP 31 Mar 2025
Woodline Partners LP 2.4% $28,518,615 2,114,056 Woodline Partners LP 31 Dec 2024

As of 30 Sep 2025, 233 institutional investors reported holding 100,723,656 shares of Travere Therapeutics, Inc. - COMMON STOCK (TVTX). This represents 112% of the company’s total 90,318,827 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 12% 10,599,660 +11% 0.12% $253,305,508
BlackRock, Inc. 9% 8,100,461 -0.84% 0% $193,601,018
ARMISTICE CAPITAL, LLC 7.4% 6,724,000 -24% 5% $160,703,600
VANGUARD GROUP INC 7.3% 6,613,368 +10% 0% $158,059,496
MACQUARIE GROUP LTD 5.5% 4,984,333 -2.2% 0.14% $119,126,000
PERCEPTIVE ADVISORS LLC 4.2% 3,794,615 +355% 2.7% $90,691,299
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.9% 3,552,000 +28% 0.13% $84,892,800
STATE STREET CORP 3.6% 3,217,839 -7.6% 0% $76,906,352
FMR LLC 3.2% 2,894,148 +171% 0% $69,170,132
Rock Springs Capital Management LP 2.4% 2,164,773 +13% 3% $51,738,075
EMERALD ADVISERS, LLC 2.4% 2,146,767 +2.6% 1.6% $51,307,731
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,138,030 +6.7% 0% $51,107,077
RENAISSANCE TECHNOLOGIES LLC 1.9% 1,752,114 -30% 0.06% $41,875,525
Stephens Investment Management Group LLC 1.8% 1,599,668 0.5% $38,232,065
DEUTSCHE BANK AG\ 1.8% 1,599,295 +210% 0.01% $38,223,150
Eversept Partners, LP 1.6% 1,417,204 +7.8% 2.6% $33,871,176
BANK OF AMERICA CORP /DE/ 1.5% 1,398,930 -14% 0% $33,434,428
GOLDMAN SACHS GROUP INC 1.4% 1,273,903 -18% 0% $30,446,282
WELLINGTON MANAGEMENT GROUP LLP 1.3% 1,201,469 +3332% 0.01% $28,715,110
EMERALD MUTUAL FUND ADVISERS TRUST 1.3% 1,200,942 +5.2% 1.5% $28,702,514
RA CAPITAL MANAGEMENT, L.P. 1.3% 1,150,000 0% 0.34% $27,485,000
MORGAN STANLEY 1.2% 1,117,036 -29% 0% $26,697,170
JENNISON ASSOCIATES LLC 1.2% 1,084,350 +41% 0.02% $25,915,965
Nuveen, LLC 1.2% 1,078,691 -9.7% 0.01% $25,780,715
Aberdeen Group plc 1.1% 967,385 +7.9% 0.04% $23,120,502

Institutional Holders of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 583,914 $22,296,303 +$14,694,794 $38.21 12
2025 Q3 100,723,656 $2,407,289,690 +$19,761,117 $23.90 233
2025 Q2 100,531,669 $1,487,837,300 +$12,972,113 $14.80 208
2025 Q1 98,007,579 $1,771,747,935 +$87,075,492 $17.92 214
2024 Q4 95,064,656 $1,655,970,084 +$205,306,696 $17.42 194
2024 Q3 82,663,245 $1,156,484,130 -$77,850,559 $13.99 177
2024 Q2 88,022,878 $735,956,555 +$16,235,981 $8.22 171
2024 Q1 87,615,146 $675,466,664 +$15,631,310 $7.71 171
2023 Q4 48,804 $438,748 -$1,690,983 $8.99 2
2023 Q3 82,359,217 $736,300,751 -$62,494,422 $8.94 165
2023 Q2 82,636,073 $1,269,282,116 -$87,606,839 $15.36 163
2023 Q1 84,151,882 $1,892,538,461 +$264,651,814 $22.49 171
2022 Q4 72,707,813 $1,529,707,454 +$30,865,593 $21.03 151
2022 Q3 65,856,415 $1,622,813,916 -$1,532,465 $24.64 161
2022 Q2 68,866,420 $1,668,868,731 +$17,092,318 $24.23 162
2022 Q1 68,329,588 $1,760,353,030 +$101,218,658 $25.77 163
2021 Q4 60,643,970 $1,882,128,574 +$62,189,797 $31.04 161
2021 Q3 60,792,242 $1,474,373,120 +$7,958,400 $24.25 144
2021 Q2 60,511,087 $882,913,811 -$73,509,423 $14.59 129
2021 Q1 62,586,224 $1,562,525,391 +$255,440,042 $24.97 147
2020 Q4 52,203,067 $1,420,860,359 +$1,414,485,322 $27.26 133